Double-blind Randomised Placebo-controlled Phase III Study of an E. coli Extract plus 5-Fluorouracil versus 5-Fluorouracil in Patients with Advanced Colorectal Cancer
暂无分享,去创建一个
B. Schneider | C. Unger | S. Hockertz | A. Kruse | H. Clevert | C. Clemm | B. Häring | B. Weber | Anne Thumann | Markus Kalousek
[1] T. Hickish,et al. Irinotecan in second-line treatment of metastatic colorectal cancer: improved survival and cost-effect compared with infusional 5-FU. , 1999, European journal of cancer.
[2] J. Wardle,et al. A patient preference study comparing raltitrexed ('Tomudex') and bolus or infusional 5-fluorouracil regimens in advanced colorectal cancer: influence of side-effects and administration attributes. , 1999, European journal of cancer care.
[3] J. Sitzia,et al. Patients' experiences of chemotherapy: side-effects associated with 5-fluorouracil + folinic acid in the treatment of colorectal cancer. , 1998, Journal of clinical nursing.
[4] H. Bleiberg. Colorectal cancer--is there an alternative to 5-FU? , 1997, European journal of cancer.
[5] E. Gamelin,et al. Relationship between 5‐fluorouracil (5‐FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5‐FU , 1996, Cancer.
[6] H. Loppnow,et al. Cytokine production by mononuclear cells following stimulation with a peptide-containing, endotoxin-free Escherichia coli extract. , 1995, Arzneimittel-Forschung.
[7] H. Wieand,et al. Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] U. Zeymer,et al. [The cardiotoxic side effects of 5-fluorouracil]. , 1991, Deutsche medizinische Wochenschrift.
[9] C. Heidelberger,et al. Fluorinated pyrimidines. , 1963, Progress in nucleic acid research and molecular biology.
[10] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[11] M. Pirovano,et al. Modulated 5-fluorouracil (5-FU) regimens in advanced colorectal cancer: a critical review of comparative studies. , 1996, European journal of cancer.
[12] E. Thiel,et al. A Multicenter Prospective Randomized Trial with Assessment of Quality of Life in Patients with Metastatic Colorectal Carcinoma Comparing Interferon α-2b and Folinic Acid as Modulators of 5-Fluorouracil , 1994 .
[13] P. Rougier,et al. Phase II trial of 7-day continuous 5-fluorouracil infusion in the treatment of advanced colorectal carcinoma. , 1992, Oncology.
[14] N. Niederle,et al. [Cardiac side effects of 5-fluorouracil]. , 1990, Deutsche medizinische Wochenschrift.